Innoveix Recalls All Sterile Compounded Drugs

2019-10-11 |

The U.S. FDA announced that Innoveix Pharmaceuticals is voluntarily recalling all sterile compounded drug products due to lack of sterility assurance. The affected products are injectable Human Chorionic Gonadotropin (HCG) and injectable Sermorelin w/GHRP2. Read FDA safety alert.